PRODUCT LITERATURE

Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia

---

Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA reductase inhibitor (i.e. statin)
with particularly strong inhibitory efects on hepatic cholesterol synthesis, and ezetimibe, which inhibits the intestinal
absorption of cholesterol. A fxed-dose combination (FDC) of rosuvastatin/ezetimibe is indicated as an adjunctive therapy
to diet for the management of primary hypercholesterolemia in adults in numerous countries worldwide

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Rosufer

Specific Detail Info

American Journal of Cardiovascular Drugs

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment